{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:02:41Z","timestamp":1780131761101,"version":"3.54.0"},"reference-count":290,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FOC"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:p>Adenoviruses historically have been one of the main vectors used in human gene therapy. To date, the majority of brain tumor trials of these vectors have used replication-defective viruses. The relative lack of success obtained with replication-defective vectors has prompted a search for new and improved therapies. In this context, oncolytic (conditionally replicative) adenoviruses, which selectively bind and replicate only in tumor cells, have gained increasing importance. These adenoviruses, once they are rendered conditionally replicative by transductional and transcriptional modifications, offer significant promise for patients with malignant glioma. In this review, the authors discuss the genetic approaches to adenoviral modification and their applications in the field of neurooncology.<\/jats:p>","DOI":"10.3171\/foc.2006.20.4.1","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T07:16:29Z","timestamp":1201158989000},"page":"E19","source":"Crossref","is-referenced-by-count":28,"title":["Oncolytic adenoviral therapy for glioblastoma multiforme"],"prefix":"10.3171","volume":"20","author":[{"given":"Adam M.","family":"Sonabend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya V.","family":"Ulasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej S.","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"47171","DOI":"10.1074\/jbc.M104334200","article-title":"Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes","volume":"276","author":"Adachi","year":"2001"},{"key":"b2-sonabend20-4-19","series-title":"Cancer Res","first-page":"4305","article-title":"Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors","volume":"60","author":"Adachi","year":"2000"},{"key":"b3-sonabend20-4-19","series-title":"Nat Biotechnol","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/77283","article-title":"Replicative adenoviruses for cancer therapy","volume":"18","author":"Alemany","year":"2000"},{"key":"b4-sonabend20-4-19","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/jnci\/dji340","article-title":"Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance","volume":"97","author":"Alonso","year":"2005"},{"key":"b5-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3171\/jns.2000.92.6.1002","article-title":"Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor","volume":"92","author":"Asaoka","year":"2000"},{"key":"b6-sonabend20-4-19","series-title":"N Engl J Med","first-page":"2004","article-title":"Somatic mutations of EGFR in colorectal cancers and glioblastomas","volume":"351","author":"Barber"},{"key":"b7-sonabend20-4-19","series-title":"Cancer Res","first-page":"1271","article-title":"The flt-1 promoter for transcriptional targeting of teratocarcinoma","volume":"62","author":"Bauerschmitz","year":"2002"},{"key":"b8-sonabend20-4-19","series-title":"Neurosurgery","first-page":"380","article-title":"Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery","volume":"49","author":"Bello","year":"2001"},{"key":"b9-sonabend20-4-19","series-title":"Science","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997"},{"key":"b10-sonabend20-4-19","series-title":"Lab Invest","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/labinvest.3780336","article-title":"Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13","volume":"81","author":"Bernard","year":"2001"},{"key":"b11-sonabend20-4-19","series-title":"Science","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996"},{"key":"b12-sonabend20-4-19","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1038\/sj.onc.1204955","article-title":"Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill","volume":"20","author":"Boyd","year":"2001"},{"key":"b13-sonabend20-4-19","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/jnen\/63.12.1274","article-title":"Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors","volume":"63","author":"Brady","year":"2004"},{"key":"b14-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/A:1006444300504","article-title":"Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents","volume":"46","author":"Chatterjee","year":"2000"},{"key":"b15-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/sj.cgt.7700752","article-title":"Cancer-specific activation of the survivin promoter and its potential use in gene therapy","volume":"11","author":"Chen","year":"2004"},{"key":"b16-sonabend20-4-19","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","article-title":"A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting","volume":"10","author":"Chiocca","year":"2004"},{"key":"b17-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1074\/jbc.M009604200","article-title":"Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium","volume":"276","author":"Christian","year":"2001"},{"key":"b18-sonabend20-4-19","series-title":"Science","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","article-title":"Reovirus therapy of tumors with activated Ras pathway","volume":"282","author":"Coffey","year":"1998"},{"key":"b19-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.cgt.7700750","article-title":"Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization","volume":"12","author":"Conrad","year":"2005"},{"key":"b20-sonabend20-4-19","series-title":"Cancer Res","first-page":"5334","article-title":"Expression of the class VI intermediate filament nestin in human central nervous system tumors","volume":"52","author":"Dahlstrand","year":"1992"},{"key":"b21-sonabend20-4-19","series-title":"J Cancer Res Clin Oncol","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00432-002-0343-4","article-title":"Expression of survivin in primary glioblastomas","volume":"128","author":"Das","year":"2002"},{"key":"b22-sonabend20-4-19","series-title":"Mol Med","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/BF03401786","article-title":"Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer\/testis antigen","volume":"6","author":"Debinski","year":"2000"},{"key":"b23-sonabend20-4-19","series-title":"Nat Biotechnol","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nbt0598-449","article-title":"Novel anti-brain tumor cytotoxins specific for cancer cells","volume":"16","author":"Debinski","year":"1998"},{"key":"b24-sonabend20-4-19","series-title":"Int J Oncol","first-page":"481","article-title":"Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme","volume":"15","author":"Debinski","year":"1999"},{"key":"b25-sonabend20-4-19","series-title":"Am J Clin Pathol","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/ajcp\/107.5.548","article-title":"Differential telomerase expression in human primary intracranial tumors","volume":"107","author":"DeMasters","year":"1997"},{"key":"b26-sonabend20-4-19","series-title":"J Virol","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1128\/JVI.74.15.6875-6884.2000","article-title":"Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells","volume":"74","author":"Dmitriev","year":"2000"},{"key":"b27-sonabend20-4-19","series-title":"J Biomed Mater Res","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO;2-R","article-title":"Targeted drug delivery to C6 glioma by transferrin-coupled liposomes","volume":"51","author":"Eavarone","year":"2000"},{"key":"b28-sonabend20-4-19","series-title":"Cancer Res","first-page":"5657","article-title":"The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma","volume":"62","author":"Ehtesham","year":"2002"},{"issue":"3","key":"b29-sonabend20-4-19","series-title":"Neurosurg Focus","first-page":"E5","article-title":"Stem cell therapies for malignant glioma","volume":"19","author":"Ehtesham","year":"2005"},{"key":"b30-sonabend20-4-19","series-title":"Cancer Res","first-page":"2164","article-title":"Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo","volume":"51","author":"Ekstrand","year":"1991"},{"key":"b31-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1023\/A:1005800114912","article-title":"Signal transduction pathways and their relevance in human astrocytomas","volume":"35","author":"Feldkamp","year":"1997"},{"key":"b32-sonabend20-4-19","series-title":"Virology","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0042-6822(78)90353-7","article-title":"Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue","volume":"91","author":"Frost","year":"1978"},{"key":"b33-sonabend20-4-19","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/jnci\/95.9.652","article-title":"Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway","volume":"95","author":"Fueyo","year":"2003"},{"key":"b34-sonabend20-4-19","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo","volume":"19","author":"Fueyo","year":"2000"},{"key":"b35-sonabend20-4-19","series-title":"Cancer Res","first-page":"1233","article-title":"Expression of two types of receptor for insulin-like growth factors in human malignant glioma","volume":"48","author":"Gammeltoft","year":"1988"},{"key":"b36-sonabend20-4-19","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"8936","DOI":"10.1158\/0008-5472.CAN-05-0581","article-title":"Decreased replication ability of E1-deleted adenoviruses correlates with increased brain tumor malignancy","volume":"65","author":"Ghosh","year":"2005"},{"key":"b37-sonabend20-4-19","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1158\/1078-0432.CCR-05-1892","article-title":"Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan","volume":"12","author":"Gomez-Manzano","year":"2006"},{"key":"b38-sonabend20-4-19","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/01.WNL.0000133302.15022.7F","article-title":"from bench to bedside","volume":"63","author":"Gomez-Manzano","year":"2004"},{"key":"b39-sonabend20-4-19","series-title":"Gene","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0378-1119(98)00585-X","article-title":"Cell type specificity of the human endoglin promoter","volume":"227","author":"Graulich","year":"1999"},{"key":"b40-sonabend20-4-19","series-title":"Clin Cancer Res","first-page":"641","article-title":"Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids","volume":"7","author":"Grill","year":"2001"},{"key":"b41-sonabend20-4-19","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1017\/S0317167100034272","article-title":"Ras activation in astrocytomas and neurofibromas","volume":"25","author":"Guha","year":"1998"},{"key":"b42-sonabend20-4-19","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ijc.2910600206","article-title":"Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop","volume":"60","author":"Guha","year":"1995"},{"key":"b43-sonabend20-4-19","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/sj.onc.1201455","article-title":"Proliferation of human malignant astrocytomas is dependent on Ras activation","volume":"15","author":"Guha","year":"1997"},{"key":"b44-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/sj.cgt.7700455","article-title":"Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus","volume":"9","author":"Habib","year":"2002"},{"key":"b45-sonabend20-4-19","series-title":"Anticancer Res","first-page":"2315","article-title":"EGFR but not PDGFR-beta expression correlates to the antiproliferative effect of growth factor withdrawal in glioblastoma multiforme cell lines","volume":"23","author":"Halatsch","year":"2003"},{"key":"b46-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/2057","article-title":"p53-dependent cell death\/apoptosis is required for a productive adenovirus infection","volume":"4","author":"Hall","year":"1998"},{"key":"b47-sonabend20-4-19","series-title":"Acta Neurochir Suppl","first-page":"125","article-title":"Gene therapy of gliomas","volume":"88","author":"Hamel","year":"2003"},{"key":"b48-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF01324703","article-title":"Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease","volume":"16","author":"Hamel","year":"1993"},{"key":"b49-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3171\/jns.2000.93.4.0618","article-title":"Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker","volume":"93","author":"Harada","year":"2000"},{"key":"b50-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Heise","year":"2000"},{"key":"b51-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"Heise","year":"1997"},{"key":"b52-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1089\/hum.1998.9.16-2363","article-title":"The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures","volume":"9","author":"Hemmi","year":"1998"},{"key":"b53-sonabend20-4-19","series-title":"Mol Cell Biol","first-page":"981","article-title":"Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors","volume":"12","author":"Hu","year":"1992"},{"key":"b54-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1074\/jbc.272.5.2927","article-title":"The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling","volume":"272","author":"Huang","year":"1997"},{"key":"b55-sonabend20-4-19","series-title":"Growth Factors","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/08977199609003217","article-title":"Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor","volume":"13","author":"Ikeda","year":"1996"},{"key":"b56-sonabend20-4-19","series-title":"Cancer Res","first-page":"895","article-title":"Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo","volume":"59","author":"Im","year":"1999"},{"key":"b57-sonabend20-4-19","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1054\/bjoc.2000.1734","article-title":"Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF","volume":"84","author":"Im","year":"2001"},{"key":"b58-sonabend20-4-19","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00386257","article-title":"Altered expression of antithrombotic molecules in human glioma vessels","volume":"87","author":"Isaka","year":"1994"},{"key":"b59-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1089\/hum.1997.8.18-2239","article-title":"Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery","volume":"8","author":"Jaggar","year":"1997"},{"key":"b60-sonabend20-4-19","series-title":"Front Biosci","doi-asserted-by":"publisher","first-page":"d577","DOI":"10.2741\/923","article-title":"Oncolytic adenoviruses for malignant glioma therapy","volume":"8","author":"Jiang","year":"2003"},{"key":"b61-sonabend20-4-19","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1593\/neo.04391","article-title":"Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas","volume":"7","author":"Jiang","year":"2005"},{"key":"b62-sonabend20-4-19","series-title":"Cancer Res","first-page":"4926","article-title":"Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398","volume":"60","author":"Joki","year":"2000"},{"key":"b63-sonabend20-4-19","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/cncr.11122","article-title":"Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis","volume":"97","author":"Kajiwara","year":"2003"},{"key":"b64-sonabend20-4-19","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1158\/0008-5472.CAN-04-3227","article-title":"An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor","volume":"65","author":"Kambara","year":"2005"},{"key":"b65-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/78638","article-title":"A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer","volume":"6","author":"Khuri","year":"2000"},{"key":"b66-sonabend20-4-19","series-title":"Science","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994"},{"key":"b67-sonabend20-4-19","series-title":"Arch Pathol Lab Med","first-page":"826","article-title":"Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels","volume":"127","author":"Kleinschmidt-DeMasters","year":"2003"},{"key":"b68-sonabend20-4-19","series-title":"Oncol Rep","first-page":"73","article-title":"Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy","volume":"12","author":"Kohno","year":"2004"},{"key":"b69-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1089\/104303402753812421","article-title":"Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells","volume":"13","author":"Komata","year":"2002"},{"key":"b70-sonabend20-4-19","series-title":"Cancer Res","first-page":"5796","article-title":"Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter","volume":"61","author":"Komata","year":"2001"},{"key":"b71-sonabend20-4-19","series-title":"Acta Neurochir Suppl","first-page":"105","article-title":"Convection enhanced delivery of IL13-pE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies","volume":"88","author":"Kunwar","year":"2003"},{"key":"b72-sonabend20-4-19","series-title":"J Mol Neurosci","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1385\/JMN:13:1-2:177","article-title":"Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas","volume":"13","author":"Lafuente","year":"1999"},{"key":"b73-sonabend20-4-19","series-title":"Cancer Res","first-page":"5736","article-title":"Potential of the conditionally replicative adenovirus Ad5-delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy","volume":"62","author":"Lamfers","year":"2002"},{"key":"b74-sonabend20-4-19","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1158\/1078-0432.CCR-04-0393","article-title":"Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity","volume":"10","author":"Lammering","year":"2004"},{"key":"b75-sonabend20-4-19","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1200\/JCO.2003.21.13.2508","article-title":"Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results","volume":"21","author":"Lang","year":"2003"},{"key":"b76-sonabend20-4-19","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(95)91865-5","article-title":"Telomerase activity in human brain tumors","volume":"346","author":"Langford","year":"1995"},{"key":"b77-sonabend20-4-19","series-title":"FASEB J","first-page":"1919","article-title":"NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha-dependent mechanism","volume":"17","author":"Laurent","year":"2003"},{"key":"b78-sonabend20-4-19","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/00006123-199805000-00099","article-title":"Telomerase activity in human gliomas","volume":"42","author":"Le","year":"1998"},{"key":"b79-sonabend20-4-19","series-title":"Nat Rev Drug Discov","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrd1414","article-title":"Targeted therapy for brain tumors","volume":"3","author":"Lesniak","year":"2004"},{"key":"b80-sonabend20-4-19","series-title":"Curr Neurol Neurosci Rep","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11910-001-0020-z","article-title":"Drug delivery to tumors of the central nervous system","volume":"1","author":"Lesniak","year":"2001"},{"key":"b81-sonabend20-4-19","series-title":"Clin Cancer Res","first-page":"4175","article-title":"Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer","volume":"5","author":"Li","year":"1999"},{"key":"b82-sonabend20-4-19","series-title":"J Virol","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1128\/JVI.72.3.2055-2061.1998","article-title":"Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-oH kinase","volume":"72","author":"Li","year":"1998"},{"key":"b83-sonabend20-4-19","series-title":"Cancer Res","first-page":"325","article-title":"Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy","volume":"59","author":"Li","year":"1999"},{"key":"b84-sonabend20-4-19","series-title":"Mol Imaging Biol","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.mibio.2004.09.002","article-title":"Noninvasive imaging of transcriptionally restricted transgene expression following intratumoral injection of an adenovirus in which the COX-2 promoter drives a reporter gene","volume":"6","author":"Liang","year":"2004"},{"key":"b85-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3171\/jns.1999.90.6.1115","article-title":"Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens","volume":"90","author":"Liau","year":"1999"},{"key":"b86-sonabend20-4-19","series-title":"Nature","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/313144a0","article-title":"Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin","volume":"313","author":"Libermann","year":"1985"},{"key":"b87-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.cgt.7700733","article-title":"Oncolytic viral therapies","volume":"11","author":"Lin","year":"2004"},{"key":"b88-sonabend20-4-19","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1006\/bbrc.2002.6551","article-title":"Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1","volume":"291","author":"Liu","year":"2002"},{"key":"b89-sonabend20-4-19","series-title":"Mol Cancer Ther","first-page":"783","article-title":"Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy","volume":"2","author":"Liu","year":"2003"},{"key":"b90-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.gt.3301205","article-title":"Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial","volume":"7","author":"Markert","year":"2000"},{"key":"b91-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01306457","article-title":"Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains","volume":"19","author":"Maruno","year":"1994"},{"key":"b92-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1089\/hum.2004.15.1022","article-title":"Biology of adenovirus and its use as a vector for gene therapy","volume":"15","author":"McConnell","year":"2004"},{"key":"b93-sonabend20-4-19","series-title":"J Cell Biol","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1083\/jcb.200112067","article-title":"Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrinmediated uptake","volume":"158","author":"Meier","year":"2002"},{"key":"b94-sonabend20-4-19","series-title":"Cancer Res","first-page":"5738","article-title":"Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer","volume":"58","author":"Miller","year":"1998"},{"key":"b95-sonabend20-4-19","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1038\/sj.onc.1206344","article-title":"Identification of molecular subtypes of glioblastoma by gene expression profiling","volume":"22","author":"Mischel","year":"2003"},{"key":"b96-sonabend20-4-19","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/jnr.490360413","article-title":"Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression","volume":"36","author":"Miyao","year":"1993"},{"key":"b97-sonabend20-4-19","series-title":"Jpn J Cancer Res","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1349-7006.1997.tb00436.x","article-title":"Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells","volume":"88","author":"Miyao","year":"1997"},{"key":"b98-sonabend20-4-19","series-title":"Jpn J Cancer Res","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1349-7006.1999.tb00771.x","article-title":"Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy","volume":"90","author":"Miyauchi","year":"1999"},{"key":"b99-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"27948","DOI":"10.1074\/jbc.270.46.27948","article-title":"A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression","volume":"270","author":"Morishita","year":"1995"},{"key":"b100-sonabend20-4-19","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ccr.2004.11.012","article-title":"Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity","volume":"6","author":"O'Shea","year":"2004"},{"key":"b101-sonabend20-4-19","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ccr.2005.06.009","article-title":"Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy","volume":"8","author":"O'Shea","year":"2005"},{"key":"b102-sonabend20-4-19","series-title":"Cancer Res","first-page":"5031","article-title":"The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy","volume":"60","author":"Okegawa","year":"2000"},{"key":"b103-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/sj.gt.3301664","article-title":"The potential for efficacy of the modified (ICP 34.5(\u2212)) herpes simplex virus HSV1716 following intratumoral injection into human malignant glioma: a proof of principle study","volume":"9","author":"Papanastassiou","year":"2002"},{"key":"b104-sonabend20-4-19","series-title":"Nat Rev Cancer","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumors","volume":"5","author":"Parato","year":"2005"},{"key":"b105-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/nm1097-1145","article-title":"Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector","volume":"3","author":"Parr","year":"1997"},{"key":"b106-sonabend20-4-19","series-title":"Cancer Res","first-page":"2462","article-title":"Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme","volume":"63","author":"Phuong","year":"2003"},{"key":"b107-sonabend20-4-19","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1006\/bbrc.2000.2176","article-title":"Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression","volume":"268","author":"Platten","year":"2000"},{"key":"b108-sonabend20-4-19","series-title":"Cancer Res","first-page":"236","article-title":"PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter","volume":"63","author":"Pore","year":"2003"},{"key":"b109-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme","volume":"11","author":"Rainov","year":"2000"},{"key":"b110-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.gt.3301184","article-title":"Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma","volume":"7","author":"Rampling","year":"2000"},{"key":"b111-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3171\/jns.1990.72.6.0941","article-title":"Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy","volume":"72","author":"Recht","year":"1990"},{"key":"b112-sonabend20-4-19","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1056\/NEJM200409163511221","article-title":"EGFR mutations and sensitivity to gefitinib","volume":"351","author":"Rich","year":"2004"},{"key":"b113-sonabend20-4-19","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1158\/0008-5472.957.65.3","article-title":"Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673, 451","volume":"65","author":"Roberts","year":"2005"},{"key":"b114-sonabend20-4-19","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jnci\/89.1.21","article-title":"Gene therapy for cancer: what have we done and where are we going?","volume":"89","author":"Roth","year":"1997"},{"key":"b115-sonabend20-4-19","series-title":"Adv Enzyme Regul","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0065-2571(02)00039-0","article-title":"Utilization of the promoter region of the midkine gene as a tool to drive therapeutic genes in a tumor specific manner","volume":"43","author":"Sakiyama","year":"2003"},{"key":"b116-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/sj.cgt.7700158","article-title":"Adenovirus-mediated transfer of bax with caspase-8 controlled by myelin basic protein promoter exerts an enhanced cytotoxic effect in gliomas","volume":"7","author":"Shinoura","year":"2000"},{"key":"b117-sonabend20-4-19","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1158\/1078-0432.CCR-03-0267","article-title":"A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells","volume":"10","author":"Shirakawa","year":"2004"},{"key":"b118-sonabend20-4-19","series-title":"Rev Med Virol","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/rmv.490","article-title":"Conditionally replicative adenoviral vectors for malignant glioma","volume":"16","author":"Sonabend","year":"2006"},{"key":"b119-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"10107","DOI":"10.1074\/jbc.273.17.10107","article-title":"Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits","volume":"273","author":"Srinivasula","year":"1998"},{"key":"b120-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1013329832067","article-title":"Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft","volume":"55","author":"Stefanik","year":"2001"},{"key":"b121-sonabend20-4-19","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbrc.2004.06.175","article-title":"Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis","volume":"321","author":"Steinbach","year":"2004"},{"key":"b122-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.gt.3302588","article-title":"A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy","volume":"12","author":"Stoff-Khalili","year":"2005"},{"key":"b123-sonabend20-4-19","series-title":"Mol Biol Cell","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1091\/mbc.e05-02-0121","article-title":"Nucleartargeting of adenovirus type 2 requires CRM1-mediated nuclear export","volume":"16","author":"Strunze","year":"2005"},{"key":"b124-sonabend20-4-19","series-title":"Clin Cancer Res","first-page":"120","article-title":"A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency","volume":"7","author":"Suzuki","year":"2001"},{"issue":"Suppl 1","key":"b125-sonabend20-4-19","series-title":"Rocz Akad Med Bialymst","first-page":"98","article-title":"Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA","volume":"49","author":"Szpechcinski","year":"2004"},{"key":"b126-sonabend20-4-19","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/sj.bjc.6601246","article-title":"A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter","volume":"89","author":"Tomizawa","year":"2003"},{"key":"b127-sonabend20-4-19","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subGroup C adenoviruses and Group B coxsackieviruses","volume":"94","author":"Tomko","year":"1997"},{"key":"b128-sonabend20-4-19","series-title":"Cancer Res","first-page":"150","article-title":"CDKN2\/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated","volume":"56","author":"Ueki","year":"1996"},{"key":"b129-sonabend20-4-19","series-title":"J Virol","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1128\/JVI.76.6.2753-2762.2002","article-title":"Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished","volume":"76","author":"van Beusechem","year":"2002"},{"key":"b130-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/jns.2006.104.4.583","article-title":"The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma","volume":"104","author":"van Houdt","year":"2006"},{"key":"b131-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/sj.cgt.7700211","article-title":"Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter","volume":"7","author":"Vandier","year":"2000"},{"key":"b132-sonabend20-4-19","series-title":"Anticancer Res","first-page":"1357","article-title":"Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector","volume":"18","author":"Walton","year":"1998"},{"key":"b133-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3171\/jns.2005.103.6.1058","article-title":"Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy","volume":"103","author":"Wang","year":"2005"},{"key":"b134-sonabend20-4-19","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1750-3639.1996.tb00848.x","article-title":"Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas","volume":"6","author":"Watanabe","year":"1996"},{"key":"b135-sonabend20-4-19","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1073\/pnas.84.19.6899","article-title":"Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification","volume":"84","author":"Wong","year":"1987"},{"key":"b136-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/sj.gt.3302280","article-title":"Tumor-specific gene expression using the survivin promoter is further increased by hypoxia","volume":"11","author":"Yang","year":"2004"},{"key":"b137-sonabend20-4-19","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"8561","DOI":"10.1158\/1078-0432.CCR-04-0940","article-title":"Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates","volume":"10","author":"Yang","year":"2004"},{"key":"b138-sonabend20-4-19","series-title":"FASEB J","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1096\/fasebj.11.8.9240963","article-title":"Advances in adenoviral vectors: from genetic engineering to their biology","volume":"11","author":"Yeh","year":"1997"},{"key":"b139-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF02700020","article-title":"Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium","volume":"64","author":"Yu","year":"2003"},{"key":"b140-sonabend20-4-19","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1158\/0008-5472.CAN-03-3505","article-title":"Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma","volume":"64","author":"Yu","year":"2004"},{"key":"b141-sonabend20-4-19","series-title":"Cancer Res","first-page":"842","article-title":"Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration","volume":"61","author":"Yu","year":"2001"},{"key":"b142-sonabend20-4-19","series-title":"Eur J Cancer","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ejca.2004.04.014","article-title":"Midkine promoter-driven suicide gene expression and-mediated adenovirus replication produced cytotoxic effects to immortalised and tumor cells","volume":"40","author":"Yu","year":"2004"},{"key":"b143-sonabend20-4-19","series-title":"Oncol Rep","first-page":"1301","article-title":"Cell growth-and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells","volume":"10","author":"Yu","year":"2003"},{"key":"b144-sonabend20-4-19","series-title":"Oncology","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000077441","article-title":"Midkine promoter can mediate transcriptional activation of a fused suicide gene in a broader range of human breast cancer compared with c-erbB-2 promoter","volume":"66","author":"Yu","year":"2004"},{"key":"b145-sonabend20-4-19","series-title":"Zhonghua Bing Li Xue Za Zhi","first-page":"109","article-title":"[A study of gene expression of PDGFBB and PDGFR as well as level of PDGFR activity in human glioma cells.]","volume":"27","author":"Yu","year":"1998"},{"key":"b1-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"47171","DOI":"10.1074\/jbc.M104334200","article-title":"Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes","volume":"276","author":"Adachi","year":"2001"},{"key":"b2-sonabend20-4-19","series-title":"Cancer Res","first-page":"4305","article-title":"Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors","volume":"60","author":"Adachi","year":"2000"},{"key":"b3-sonabend20-4-19","series-title":"Nat Biotechnol","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/77283","article-title":"Replicative adenoviruses for cancer therapy","volume":"18","author":"Alemany","year":"2000"},{"key":"b4-sonabend20-4-19","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/jnci\/dji340","article-title":"Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance","volume":"97","author":"Alonso","year":"2005"},{"key":"b5-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3171\/jns.2000.92.6.1002","article-title":"Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor","volume":"92","author":"Asaoka","year":"2000"},{"key":"b6-sonabend20-4-19","series-title":"N Engl J Med","first-page":"2004","article-title":"Somatic mutations of EGFR in colorectal cancers and glioblastomas","volume":"351","author":"Barber"},{"key":"b7-sonabend20-4-19","series-title":"Cancer Res","first-page":"1271","article-title":"The flt-1 promoter for transcriptional targeting of teratocarcinoma","volume":"62","author":"Bauerschmitz","year":"2002"},{"key":"b8-sonabend20-4-19","series-title":"Neurosurgery","first-page":"380","article-title":"Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery","volume":"49","author":"Bello","year":"2001"},{"key":"b9-sonabend20-4-19","series-title":"Science","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997"},{"key":"b10-sonabend20-4-19","series-title":"Lab Invest","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/labinvest.3780336","article-title":"Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13","volume":"81","author":"Bernard","year":"2001"},{"key":"b11-sonabend20-4-19","series-title":"Science","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996"},{"key":"b12-sonabend20-4-19","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1038\/sj.onc.1204955","article-title":"Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill","volume":"20","author":"Boyd","year":"2001"},{"key":"b13-sonabend20-4-19","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/jnen\/63.12.1274","article-title":"Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors","volume":"63","author":"Brady","year":"2004"},{"key":"b14-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/A:1006444300504","article-title":"Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents","volume":"46","author":"Chatterjee","year":"2000"},{"key":"b15-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/sj.cgt.7700752","article-title":"Cancer-specific activation of the survivin promoter and its potential use in gene therapy","volume":"11","author":"Chen","year":"2004"},{"key":"b16-sonabend20-4-19","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","article-title":"A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting","volume":"10","author":"Chiocca","year":"2004"},{"key":"b17-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1074\/jbc.M009604200","article-title":"Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium","volume":"276","author":"Christian","year":"2001"},{"key":"b18-sonabend20-4-19","series-title":"Science","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","article-title":"Reovirus therapy of tumors with activated Ras pathway","volume":"282","author":"Coffey","year":"1998"},{"key":"b19-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.cgt.7700750","article-title":"Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization","volume":"12","author":"Conrad","year":"2005"},{"key":"b20-sonabend20-4-19","series-title":"Cancer Res","first-page":"5334","article-title":"Expression of the class VI intermediate filament nestin in human central nervous system tumors","volume":"52","author":"Dahlstrand","year":"1992"},{"key":"b21-sonabend20-4-19","series-title":"J Cancer Res Clin Oncol","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00432-002-0343-4","article-title":"Expression of survivin in primary glioblastomas","volume":"128","author":"Das","year":"2002"},{"key":"b22-sonabend20-4-19","series-title":"Mol Med","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/BF03401786","article-title":"Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer\/testis antigen","volume":"6","author":"Debinski","year":"2000"},{"key":"b23-sonabend20-4-19","series-title":"Nat Biotechnol","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nbt0598-449","article-title":"Novel anti-brain tumor cytotoxins specific for cancer cells","volume":"16","author":"Debinski","year":"1998"},{"key":"b24-sonabend20-4-19","series-title":"Int J Oncol","first-page":"481","article-title":"Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme","volume":"15","author":"Debinski","year":"1999"},{"key":"b25-sonabend20-4-19","series-title":"Am J Clin Pathol","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/ajcp\/107.5.548","article-title":"Differential telomerase expression in human primary intracranial tumors","volume":"107","author":"DeMasters","year":"1997"},{"key":"b26-sonabend20-4-19","series-title":"J Virol","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1128\/JVI.74.15.6875-6884.2000","article-title":"Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells","volume":"74","author":"Dmitriev","year":"2000"},{"key":"b27-sonabend20-4-19","series-title":"J Biomed Mater Res","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO;2-R","article-title":"Targeted drug delivery to C6 glioma by transferrin-coupled liposomes","volume":"51","author":"Eavarone","year":"2000"},{"key":"b28-sonabend20-4-19","series-title":"Cancer Res","first-page":"5657","article-title":"The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma","volume":"62","author":"Ehtesham","year":"2002"},{"issue":"3","key":"b29-sonabend20-4-19","series-title":"Neurosurg Focus","first-page":"E5","article-title":"Stem cell therapies for malignant glioma","volume":"19","author":"Ehtesham","year":"2005"},{"key":"b30-sonabend20-4-19","series-title":"Cancer Res","first-page":"2164","article-title":"Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo","volume":"51","author":"Ekstrand","year":"1991"},{"key":"b31-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1023\/A:1005800114912","article-title":"Signal transduction pathways and their relevance in human astrocytomas","volume":"35","author":"Feldkamp","year":"1997"},{"key":"b32-sonabend20-4-19","series-title":"Virology","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0042-6822(78)90353-7","article-title":"Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue","volume":"91","author":"Frost","year":"1978"},{"key":"b33-sonabend20-4-19","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/jnci\/95.9.652","article-title":"Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway","volume":"95","author":"Fueyo","year":"2003"},{"key":"b34-sonabend20-4-19","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo","volume":"19","author":"Fueyo","year":"2000"},{"key":"b35-sonabend20-4-19","series-title":"Cancer Res","first-page":"1233","article-title":"Expression of two types of receptor for insulin-like growth factors in human malignant glioma","volume":"48","author":"Gammeltoft","year":"1988"},{"key":"b36-sonabend20-4-19","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"8936","DOI":"10.1158\/0008-5472.CAN-05-0581","article-title":"Decreased replication ability of E1-deleted adenoviruses correlates with increased brain tumor malignancy","volume":"65","author":"Ghosh","year":"2005"},{"key":"b37-sonabend20-4-19","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1158\/1078-0432.CCR-05-1892","article-title":"Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan","volume":"12","author":"Gomez-Manzano","year":"2006"},{"key":"b38-sonabend20-4-19","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/01.WNL.0000133302.15022.7F","article-title":"from bench to bedside","volume":"63","author":"Gomez-Manzano","year":"2004"},{"key":"b39-sonabend20-4-19","series-title":"Gene","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0378-1119(98)00585-X","article-title":"Cell type specificity of the human endoglin promoter","volume":"227","author":"Graulich","year":"1999"},{"key":"b40-sonabend20-4-19","series-title":"Clin Cancer Res","first-page":"641","article-title":"Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids","volume":"7","author":"Grill","year":"2001"},{"key":"b41-sonabend20-4-19","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1017\/S0317167100034272","article-title":"Ras activation in astrocytomas and neurofibromas","volume":"25","author":"Guha","year":"1998"},{"key":"b42-sonabend20-4-19","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ijc.2910600206","article-title":"Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop","volume":"60","author":"Guha","year":"1995"},{"key":"b43-sonabend20-4-19","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/sj.onc.1201455","article-title":"Proliferation of human malignant astrocytomas is dependent on Ras activation","volume":"15","author":"Guha","year":"1997"},{"key":"b44-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/sj.cgt.7700455","article-title":"Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus","volume":"9","author":"Habib","year":"2002"},{"key":"b45-sonabend20-4-19","series-title":"Anticancer Res","first-page":"2315","article-title":"EGFR but not PDGFR-beta expression correlates to the antiproliferative effect of growth factor withdrawal in glioblastoma multiforme cell lines","volume":"23","author":"Halatsch","year":"2003"},{"key":"b46-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/2057","article-title":"p53-dependent cell death\/apoptosis is required for a productive adenovirus infection","volume":"4","author":"Hall","year":"1998"},{"key":"b47-sonabend20-4-19","series-title":"Acta Neurochir Suppl","first-page":"125","article-title":"Gene therapy of gliomas","volume":"88","author":"Hamel","year":"2003"},{"key":"b48-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF01324703","article-title":"Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease","volume":"16","author":"Hamel","year":"1993"},{"key":"b49-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3171\/jns.2000.93.4.0618","article-title":"Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker","volume":"93","author":"Harada","year":"2000"},{"key":"b50-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Heise","year":"2000"},{"key":"b51-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"Heise","year":"1997"},{"key":"b52-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1089\/hum.1998.9.16-2363","article-title":"The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures","volume":"9","author":"Hemmi","year":"1998"},{"key":"b53-sonabend20-4-19","series-title":"Mol Cell Biol","first-page":"981","article-title":"Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors","volume":"12","author":"Hu","year":"1992"},{"key":"b54-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1074\/jbc.272.5.2927","article-title":"The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling","volume":"272","author":"Huang","year":"1997"},{"key":"b55-sonabend20-4-19","series-title":"Growth Factors","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/08977199609003217","article-title":"Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor","volume":"13","author":"Ikeda","year":"1996"},{"key":"b56-sonabend20-4-19","series-title":"Cancer Res","first-page":"895","article-title":"Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo","volume":"59","author":"Im","year":"1999"},{"key":"b57-sonabend20-4-19","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1054\/bjoc.2000.1734","article-title":"Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF","volume":"84","author":"Im","year":"2001"},{"key":"b58-sonabend20-4-19","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00386257","article-title":"Altered expression of antithrombotic molecules in human glioma vessels","volume":"87","author":"Isaka","year":"1994"},{"key":"b59-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1089\/hum.1997.8.18-2239","article-title":"Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery","volume":"8","author":"Jaggar","year":"1997"},{"key":"b60-sonabend20-4-19","series-title":"Front Biosci","doi-asserted-by":"publisher","first-page":"d577","DOI":"10.2741\/923","article-title":"Oncolytic adenoviruses for malignant glioma therapy","volume":"8","author":"Jiang","year":"2003"},{"key":"b61-sonabend20-4-19","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1593\/neo.04391","article-title":"Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas","volume":"7","author":"Jiang","year":"2005"},{"key":"b62-sonabend20-4-19","series-title":"Cancer Res","first-page":"4926","article-title":"Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398","volume":"60","author":"Joki","year":"2000"},{"key":"b63-sonabend20-4-19","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/cncr.11122","article-title":"Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis","volume":"97","author":"Kajiwara","year":"2003"},{"key":"b64-sonabend20-4-19","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1158\/0008-5472.CAN-04-3227","article-title":"An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor","volume":"65","author":"Kambara","year":"2005"},{"key":"b65-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/78638","article-title":"A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer","volume":"6","author":"Khuri","year":"2000"},{"key":"b66-sonabend20-4-19","series-title":"Science","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994"},{"key":"b67-sonabend20-4-19","series-title":"Arch Pathol Lab Med","first-page":"826","article-title":"Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels","volume":"127","author":"Kleinschmidt-DeMasters","year":"2003"},{"key":"b68-sonabend20-4-19","series-title":"Oncol Rep","first-page":"73","article-title":"Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy","volume":"12","author":"Kohno","year":"2004"},{"key":"b69-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1089\/104303402753812421","article-title":"Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells","volume":"13","author":"Komata","year":"2002"},{"key":"b70-sonabend20-4-19","series-title":"Cancer Res","first-page":"5796","article-title":"Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter","volume":"61","author":"Komata","year":"2001"},{"key":"b71-sonabend20-4-19","series-title":"Acta Neurochir Suppl","first-page":"105","article-title":"Convection enhanced delivery of IL13-pE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies","volume":"88","author":"Kunwar","year":"2003"},{"key":"b72-sonabend20-4-19","series-title":"J Mol Neurosci","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1385\/JMN:13:1-2:177","article-title":"Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas","volume":"13","author":"Lafuente","year":"1999"},{"key":"b73-sonabend20-4-19","series-title":"Cancer Res","first-page":"5736","article-title":"Potential of the conditionally replicative adenovirus Ad5-delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy","volume":"62","author":"Lamfers","year":"2002"},{"key":"b74-sonabend20-4-19","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1158\/1078-0432.CCR-04-0393","article-title":"Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity","volume":"10","author":"Lammering","year":"2004"},{"key":"b75-sonabend20-4-19","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1200\/JCO.2003.21.13.2508","article-title":"Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results","volume":"21","author":"Lang","year":"2003"},{"key":"b76-sonabend20-4-19","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(95)91865-5","article-title":"Telomerase activity in human brain tumors","volume":"346","author":"Langford","year":"1995"},{"key":"b77-sonabend20-4-19","series-title":"FASEB J","first-page":"1919","article-title":"NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha-dependent mechanism","volume":"17","author":"Laurent","year":"2003"},{"key":"b78-sonabend20-4-19","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/00006123-199805000-00099","article-title":"Telomerase activity in human gliomas","volume":"42","author":"Le","year":"1998"},{"key":"b79-sonabend20-4-19","series-title":"Nat Rev Drug Discov","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrd1414","article-title":"Targeted therapy for brain tumors","volume":"3","author":"Lesniak","year":"2004"},{"key":"b80-sonabend20-4-19","series-title":"Curr Neurol Neurosci Rep","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11910-001-0020-z","article-title":"Drug delivery to tumors of the central nervous system","volume":"1","author":"Lesniak","year":"2001"},{"key":"b81-sonabend20-4-19","series-title":"Clin Cancer Res","first-page":"4175","article-title":"Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer","volume":"5","author":"Li","year":"1999"},{"key":"b82-sonabend20-4-19","series-title":"J Virol","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1128\/JVI.72.3.2055-2061.1998","article-title":"Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-oH kinase","volume":"72","author":"Li","year":"1998"},{"key":"b83-sonabend20-4-19","series-title":"Cancer Res","first-page":"325","article-title":"Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy","volume":"59","author":"Li","year":"1999"},{"key":"b84-sonabend20-4-19","series-title":"Mol Imaging Biol","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.mibio.2004.09.002","article-title":"Noninvasive imaging of transcriptionally restricted transgene expression following intratumoral injection of an adenovirus in which the COX-2 promoter drives a reporter gene","volume":"6","author":"Liang","year":"2004"},{"key":"b85-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3171\/jns.1999.90.6.1115","article-title":"Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens","volume":"90","author":"Liau","year":"1999"},{"key":"b86-sonabend20-4-19","series-title":"Nature","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/313144a0","article-title":"Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin","volume":"313","author":"Libermann","year":"1985"},{"key":"b87-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.cgt.7700733","article-title":"Oncolytic viral therapies","volume":"11","author":"Lin","year":"2004"},{"key":"b88-sonabend20-4-19","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1006\/bbrc.2002.6551","article-title":"Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1","volume":"291","author":"Liu","year":"2002"},{"key":"b89-sonabend20-4-19","series-title":"Mol Cancer Ther","first-page":"783","article-title":"Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy","volume":"2","author":"Liu","year":"2003"},{"key":"b90-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.gt.3301205","article-title":"Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial","volume":"7","author":"Markert","year":"2000"},{"key":"b91-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01306457","article-title":"Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains","volume":"19","author":"Maruno","year":"1994"},{"key":"b92-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1089\/hum.2004.15.1022","article-title":"Biology of adenovirus and its use as a vector for gene therapy","volume":"15","author":"McConnell","year":"2004"},{"key":"b93-sonabend20-4-19","series-title":"J Cell Biol","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1083\/jcb.200112067","article-title":"Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrinmediated uptake","volume":"158","author":"Meier","year":"2002"},{"key":"b94-sonabend20-4-19","series-title":"Cancer Res","first-page":"5738","article-title":"Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer","volume":"58","author":"Miller","year":"1998"},{"key":"b95-sonabend20-4-19","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1038\/sj.onc.1206344","article-title":"Identification of molecular subtypes of glioblastoma by gene expression profiling","volume":"22","author":"Mischel","year":"2003"},{"key":"b96-sonabend20-4-19","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/jnr.490360413","article-title":"Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression","volume":"36","author":"Miyao","year":"1993"},{"key":"b97-sonabend20-4-19","series-title":"Jpn J Cancer Res","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1349-7006.1997.tb00436.x","article-title":"Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells","volume":"88","author":"Miyao","year":"1997"},{"key":"b98-sonabend20-4-19","series-title":"Jpn J Cancer Res","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1349-7006.1999.tb00771.x","article-title":"Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy","volume":"90","author":"Miyauchi","year":"1999"},{"key":"b99-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"27948","DOI":"10.1074\/jbc.270.46.27948","article-title":"A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression","volume":"270","author":"Morishita","year":"1995"},{"key":"b100-sonabend20-4-19","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ccr.2004.11.012","article-title":"Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity","volume":"6","author":"O'Shea","year":"2004"},{"key":"b101-sonabend20-4-19","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ccr.2005.06.009","article-title":"Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy","volume":"8","author":"O'Shea","year":"2005"},{"key":"b102-sonabend20-4-19","series-title":"Cancer Res","first-page":"5031","article-title":"The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy","volume":"60","author":"Okegawa","year":"2000"},{"key":"b103-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/sj.gt.3301664","article-title":"The potential for efficacy of the modified (ICP 34.5(\u2212)) herpes simplex virus HSV1716 following intratumoral injection into human malignant glioma: a proof of principle study","volume":"9","author":"Papanastassiou","year":"2002"},{"key":"b104-sonabend20-4-19","series-title":"Nat Rev Cancer","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumors","volume":"5","author":"Parato","year":"2005"},{"key":"b105-sonabend20-4-19","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/nm1097-1145","article-title":"Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector","volume":"3","author":"Parr","year":"1997"},{"key":"b106-sonabend20-4-19","series-title":"Cancer Res","first-page":"2462","article-title":"Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme","volume":"63","author":"Phuong","year":"2003"},{"key":"b107-sonabend20-4-19","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1006\/bbrc.2000.2176","article-title":"Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression","volume":"268","author":"Platten","year":"2000"},{"key":"b108-sonabend20-4-19","series-title":"Cancer Res","first-page":"236","article-title":"PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter","volume":"63","author":"Pore","year":"2003"},{"key":"b109-sonabend20-4-19","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme","volume":"11","author":"Rainov","year":"2000"},{"key":"b110-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.gt.3301184","article-title":"Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma","volume":"7","author":"Rampling","year":"2000"},{"key":"b111-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3171\/jns.1990.72.6.0941","article-title":"Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy","volume":"72","author":"Recht","year":"1990"},{"key":"b112-sonabend20-4-19","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1056\/NEJM200409163511221","article-title":"EGFR mutations and sensitivity to gefitinib","volume":"351","author":"Rich","year":"2004"},{"key":"b113-sonabend20-4-19","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1158\/0008-5472.957.65.3","article-title":"Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673, 451","volume":"65","author":"Roberts","year":"2005"},{"key":"b114-sonabend20-4-19","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jnci\/89.1.21","article-title":"Gene therapy for cancer: what have we done and where are we going?","volume":"89","author":"Roth","year":"1997"},{"key":"b115-sonabend20-4-19","series-title":"Adv Enzyme Regul","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0065-2571(02)00039-0","article-title":"Utilization of the promoter region of the midkine gene as a tool to drive therapeutic genes in a tumor specific manner","volume":"43","author":"Sakiyama","year":"2003"},{"key":"b116-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/sj.cgt.7700158","article-title":"Adenovirus-mediated transfer of bax with caspase-8 controlled by myelin basic protein promoter exerts an enhanced cytotoxic effect in gliomas","volume":"7","author":"Shinoura","year":"2000"},{"key":"b117-sonabend20-4-19","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1158\/1078-0432.CCR-03-0267","article-title":"A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells","volume":"10","author":"Shirakawa","year":"2004"},{"key":"b118-sonabend20-4-19","series-title":"Rev Med Virol","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/rmv.490","article-title":"Conditionally replicative adenoviral vectors for malignant glioma","volume":"16","author":"Sonabend","year":"2006"},{"key":"b119-sonabend20-4-19","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"10107","DOI":"10.1074\/jbc.273.17.10107","article-title":"Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits","volume":"273","author":"Srinivasula","year":"1998"},{"key":"b120-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1013329832067","article-title":"Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft","volume":"55","author":"Stefanik","year":"2001"},{"key":"b121-sonabend20-4-19","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbrc.2004.06.175","article-title":"Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis","volume":"321","author":"Steinbach","year":"2004"},{"key":"b122-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.gt.3302588","article-title":"A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy","volume":"12","author":"Stoff-Khalili","year":"2005"},{"key":"b123-sonabend20-4-19","series-title":"Mol Biol Cell","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1091\/mbc.e05-02-0121","article-title":"Nucleartargeting of adenovirus type 2 requires CRM1-mediated nuclear export","volume":"16","author":"Strunze","year":"2005"},{"key":"b124-sonabend20-4-19","series-title":"Clin Cancer Res","first-page":"120","article-title":"A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency","volume":"7","author":"Suzuki","year":"2001"},{"issue":"Suppl 1","key":"b125-sonabend20-4-19","series-title":"Rocz Akad Med Bialymst","first-page":"98","article-title":"Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA","volume":"49","author":"Szpechcinski","year":"2004"},{"key":"b126-sonabend20-4-19","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/sj.bjc.6601246","article-title":"A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter","volume":"89","author":"Tomizawa","year":"2003"},{"key":"b127-sonabend20-4-19","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subGroup C adenoviruses and Group B coxsackieviruses","volume":"94","author":"Tomko","year":"1997"},{"key":"b128-sonabend20-4-19","series-title":"Cancer Res","first-page":"150","article-title":"CDKN2\/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated","volume":"56","author":"Ueki","year":"1996"},{"key":"b129-sonabend20-4-19","series-title":"J Virol","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1128\/JVI.76.6.2753-2762.2002","article-title":"Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished","volume":"76","author":"van Beusechem","year":"2002"},{"key":"b130-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/jns.2006.104.4.583","article-title":"The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma","volume":"104","author":"van Houdt","year":"2006"},{"key":"b131-sonabend20-4-19","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/sj.cgt.7700211","article-title":"Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter","volume":"7","author":"Vandier","year":"2000"},{"key":"b132-sonabend20-4-19","series-title":"Anticancer Res","first-page":"1357","article-title":"Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector","volume":"18","author":"Walton","year":"1998"},{"key":"b133-sonabend20-4-19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3171\/jns.2005.103.6.1058","article-title":"Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy","volume":"103","author":"Wang","year":"2005"},{"key":"b134-sonabend20-4-19","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1750-3639.1996.tb00848.x","article-title":"Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas","volume":"6","author":"Watanabe","year":"1996"},{"key":"b135-sonabend20-4-19","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1073\/pnas.84.19.6899","article-title":"Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification","volume":"84","author":"Wong","year":"1987"},{"key":"b136-sonabend20-4-19","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/sj.gt.3302280","article-title":"Tumor-specific gene expression using the survivin promoter is further increased by hypoxia","volume":"11","author":"Yang","year":"2004"},{"key":"b137-sonabend20-4-19","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"8561","DOI":"10.1158\/1078-0432.CCR-04-0940","article-title":"Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates","volume":"10","author":"Yang","year":"2004"},{"key":"b138-sonabend20-4-19","series-title":"FASEB J","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1096\/fasebj.11.8.9240963","article-title":"Advances in adenoviral vectors: from genetic engineering to their biology","volume":"11","author":"Yeh","year":"1997"},{"key":"b139-sonabend20-4-19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF02700020","article-title":"Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium","volume":"64","author":"Yu","year":"2003"},{"key":"b140-sonabend20-4-19","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1158\/0008-5472.CAN-03-3505","article-title":"Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma","volume":"64","author":"Yu","year":"2004"},{"key":"b141-sonabend20-4-19","series-title":"Cancer Res","first-page":"842","article-title":"Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration","volume":"61","author":"Yu","year":"2001"},{"key":"b142-sonabend20-4-19","series-title":"Eur J Cancer","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ejca.2004.04.014","article-title":"Midkine promoter-driven suicide gene expression and-mediated adenovirus replication produced cytotoxic effects to immortalised and tumor cells","volume":"40","author":"Yu","year":"2004"},{"key":"b143-sonabend20-4-19","series-title":"Oncol Rep","first-page":"1301","article-title":"Cell growth-and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells","volume":"10","author":"Yu","year":"2003"},{"key":"b144-sonabend20-4-19","series-title":"Oncology","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000077441","article-title":"Midkine promoter can mediate transcriptional activation of a fused suicide gene in a broader range of human breast cancer compared with c-erbB-2 promoter","volume":"66","author":"Yu","year":"2004"},{"key":"b145-sonabend20-4-19","series-title":"Zhonghua Bing Li Xue Za Zhi","first-page":"109","article-title":"[A study of gene expression of PDGFBB and PDGFR as well as level of PDGFR activity in human glioma cells.]","volume":"27","author":"Yu","year":"1998"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/20\/4\/foc.2006.20.4.1.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/20\/4\/foc.2006.20.4.1.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/20\/4\/foc.2006.20.4.1.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:22:21Z","timestamp":1780129341000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/20\/4\/foc.2006.20.4.1.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":290,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/foc.2006.20.4.1","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}